Extrahepatic biliary obstruction caused by small-cell lung cancer

Area of Science:

• Oncology
• Gastroenterology
• Pulmonology

Background:

• Jaundice is an uncommon presentation of small-cell lung cancer (SCLC).
• Understanding the cause of jaundice is crucial for prognosis and treatment.

Purpose of the Study:

• To investigate the causes and outcomes of jaundice in patients diagnosed with SCLC.
• To differentiate prognostic implications between biliary obstruction and hepatic metastases.

Main Methods:

• Retrospective review of 12 patients with SCLC presenting with jaundice over 30 months.
• Categorization based on the cause of jaundice: pancreatic metastasis with extrahepatic biliary obstruction vs. diffuse hepatic metastases.

Main Results:

• Five patients had pancreatic metastases causing biliary obstruction; all experienced jaundice resolution with chemotherapy.
• Seven patients had diffuse hepatic metastases; most remained jaundiced despite treatment.
• Patients with pancreatic metastases had a survival exceeding 12 months; those with only hepatic metastases survived less than 8 months.

Conclusions:

• SCLC can cause jaundice via pancreatic metastasis (better prognosis) or hepatic involvement (poor prognosis).
• Extrahepatic biliary obstruction from pancreatic tumors is potentially palliable and associated with longer survival.
• Diffuse hepatic metastases causing jaundice indicate a grave prognosis in SCLC.